Today, Twist Bioscience Corp Inc’s (NASDAQ: TWST) stock gained $3.84, accounting for a 3.56% increase. Twist opened at $108.16 before trading between $113.75 and $106.39 throughout Friday’s session. The activity saw Twist’s market cap rise to $5,500,498,297 on 525,118 shares -above their 30-day average of 482,325.
About Twist Bioscience Corp
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by ‘writing’ DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
Visit Twist Bioscience Corp’s profile for more information.
About The Nasdaq Stock Market
The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world’s leading exchange for options volume and is home to the five largest US companies – Apple, Microsoft, Amazon, Alphabet and Facebook.
To get more information on Twist Bioscience Corp and to follow the company’s latest updates, you can visit the company’s profile page here: Twist Bioscience Corp’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.
Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.
The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: www.equities.com/disclaimer
Atlanta Fed President Bostic Says October Would Be ‘Reasonable’ Time To Begin Tapering Bond Purchases
Read more here: Source link